Literature DB >> 24308698

Food intake increases liver stiffness measurements and hampers reliable values in patients with chronic hepatitis B and healthy controls: the PROLIFICA experience in The Gambia.

M Lemoine1, Y Shimakawa, R Njie, H F Njai, S Nayagam, M Khalil, R Goldin, P Ingiliz, M Taal, O Nyan, T Corrah, U D'Alessandro, M Thursz.   

Abstract

BACKGROUND: By increasing the hepatic blood circulation, food intake has been suggested to increase liver stiffness measurement (LSM) values in HCV-infected patients. AIM: To investigate prospectively the effects of food intake on LSM in hepatitis B virus (HBV)-infected patients and healthy controls.
METHODS: In The Gambia, patients included in the PROLIFICA project are screened for HBV at the community level and then invited for fasting assessment including LSM. Between April 2012 and October 2012, each day, the first five participants were invited to participate in this study. After the initial examination, a standardised 850 Kcal breakfast was provided. Effect of food intake was assessed by examining mean difference of LSM, IQR and IQR/LSM at T0 (fasting LSM1), T30min (LSM2) and T120min (LSM3) respectively.
RESULTS: A total of 209 subjects were enrolled in this study (133 were HBV positive, 76 healthy controls). Unreliable measurements occurred more frequently after food intake (5%, 24% and 18% at T0, T30min and T120min respectively). In both groups, median LSM2 was significantly higher than LSM1 [6.2 (IQR: 5.4, 7.9)] vs. 4.9 (4.2, 6.2), P < 0.0001. LSM3 was still higher than the baseline, but lower than LSM2. In multivariable analysis, no factor modified the effect of breakfast on LSM. In a subgroup of patients having liver biopsies, we confirmed that food intake can overestimate liver fibrosis.
CONCLUSIONS: Food intake significantly increases liver stiffness measurement and its IQR values in patients with chronic hepatitis B as well as healthy individuals; and also the number of unreliable liver stiffness measurement values.
© 2013 John Wiley & Sons Ltd.

Entities:  

Mesh:

Year:  2013        PMID: 24308698     DOI: 10.1111/apt.12561

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  17 in total

1.  Evaluating the risk of hepatocellular carcinoma in patients with prominently elevated liver stiffness measurements by FibroScan: a multicentre study.

Authors:  Maciej Adler; Licia Larocca; Francesca M Trovato; Heather Marcinkowski; Yasmin Pasha; Simon D Taylor-Robinson
Journal:  HPB (Oxford)       Date:  2016-06-09       Impact factor: 3.647

Review 2.  Transient elastography (FibroScan(®)) with controlled attenuation parameter in the assessment of liver steatosis and fibrosis in patients with nonalcoholic fatty liver disease - Where do we stand?

Authors:  Ivana Mikolasevic; Lidija Orlic; Neven Franjic; Goran Hauser; Davor Stimac; Sandra Milic
Journal:  World J Gastroenterol       Date:  2016-08-28       Impact factor: 5.742

3.  Effect of Meal Ingestion on Liver Stiffness and Controlled Attenuation Parameter.

Authors:  Marco Silva; Pedro Costa Moreira; Armando Peixoto; Ana Luísa Santos; Susana Lopes; Regina Gonçalves; Pedro Pereira; Hélder Cardoso; Guilherme Macedo
Journal:  GE Port J Gastroenterol       Date:  2018-04-20

4.  Validation of rapid point-of-care (POC) tests for detection of hepatitis B surface antigen in field and laboratory settings in the Gambia, Western Africa.

Authors:  Harr Freeya Njai; Yusuke Shimakawa; Bakary Sanneh; Lynne Ferguson; Gibril Ndow; Maimuna Mendy; Amina Sow; Gora Lo; Coumba Toure-Kane; Junko Tanaka; Makie Taal; Umberto D'alessandro; Ramou Njie; Mark Thursz; Maud Lemoine
Journal:  J Clin Microbiol       Date:  2015-01-28       Impact factor: 5.948

5.  The gamma-glutamyl transpeptidase to platelet ratio (GPR) predicts significant liver fibrosis and cirrhosis in patients with chronic HBV infection in West Africa.

Authors:  Maud Lemoine; Yusuke Shimakawa; Shevanthi Nayagam; Mustapha Khalil; Penda Suso; Jo Lloyd; Robert Goldin; Harr-Freeya Njai; Gibril Ndow; Makie Taal; Graham Cooke; Umberto D'Alessandro; Muriel Vray; Papa Saliou Mbaye; Ramou Njie; Vincent Mallet; Mark Thursz
Journal:  Gut       Date:  2015-06-24       Impact factor: 23.059

6.  What we need to know when performing and interpreting US elastography.

Authors:  So Hyun Park; So Yeon Kim; Chong Hyun Suh; Seung Soo Lee; Kyoung Won Kim; So Jung Lee; Moon-Gyu Lee
Journal:  Clin Mol Hepatol       Date:  2016-09

7.  Are non-invasive fibrosis markers for chronic hepatitis B reliable in sub-Saharan Africa?

Authors:  Hailemichael Desalegn; Hanna Aberra; Nega Berhe; Svein G Gundersen; Asgeir Johannessen
Journal:  Liver Int       Date:  2017-03-23       Impact factor: 5.828

8.  High risk of misinterpreting liver and spleen stiffness using 2D shear-wave and transient elastography after a moderate or high calorie meal.

Authors:  Maria Kjærgaard; Maja Thiele; Christian Jansen; Bjørn Stæhr Madsen; Jan Görtzen; Christian Strassburg; Jonel Trebicka; Aleksander Krag
Journal:  PLoS One       Date:  2017-04-04       Impact factor: 3.240

9.  Exploring Interactions between Primary Hepatocytes and Non-Parenchymal Cells on Physiological and Pathological Liver Stiffness.

Authors:  Vaishaali Natarajan; Youra Moeun; Srivatsan Kidambi
Journal:  Biology (Basel)       Date:  2021-05-05

10.  High Proportion of HIV-HCV Coinfected Patients with Advanced Liver Fibrosis Requiring Hepatitis C Treatment in Haiphong, Northern Vietnam (ANRS 12262).

Authors:  Tam Nguyen Truong; Didier Laureillard; Karine Lacombe; Huong Duong Thi; Phuc Pham Thi Hanh; Lien Truong Thi Xuan; Nga Chu Thi; Anh Luong Que; Vinh Vu Hai; Nicolas Nagot; Edouard Tuaillon; Stéphanie Dominguez; Maud Lemoine
Journal:  PLoS One       Date:  2016-05-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.